The BCL2 code to dopaminergic development and Parkinson's disease

被引:17
|
作者
van der Heide, Lars P. [1 ]
Smidt, Marten P. [1 ]
机构
[1] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1090 GE Amsterdam, Netherlands
关键词
cell death; dopamine; Parkinson's disease; substantia nigra; NURR1; PITX3; BCL2; SUBSTANTIA-NIGRA; CELL-DEATH; NEURONS; PITX3; NURR1; MICE; MIDBRAIN; EXPRESSION; BAX; SURVIVAL;
D O I
10.1016/j.molmed.2013.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Continuous, nonrandom cell death during development of the dopaminergic system is carefully orchestrated by locally secreted growth factors and the expression of transcription factors to ensure every neuron is carefully placed in its appropriate position and no 'miswiring' occurs. We hypothesize that the machinery directly responsible for executing cell death is composed of a precisely calibrated array of BCL2 proteins. Paradoxically, these BCL2 proteins, required for proper development of the dopaminergic system, may also cause vulnerability of this system in the adult, as these BCL2 proteins have recently been linked to Parkinson's disease. In addition to the intriguing possibility of finding useful biomarkers for predicting later neurodegeneration, further investigation of these factors could open new paths for treating Parkinson's disease.
引用
收藏
页码:211 / 216
页数:6
相关论文
共 50 条
  • [1] Dopaminergic drugs in development for Parkinson's disease
    Korczyn, AD
    PARKINSON'S DISEASE, 2003, 91 : 267 - 271
  • [2] Development of dopaminergic neurons in zebrafish: A model of Parkinson's disease
    Hung, Karen W. Y.
    NEUROSCIENCE RESEARCH, 2008, 61 : S266 - S266
  • [3] Non-dopaminergic treatments in development for Parkinson's disease
    Fox, Susan H.
    Brotchie, Jonathan M.
    Lang, Anthony E.
    LANCET NEUROLOGY, 2008, 7 (10): : 927 - 938
  • [5] Dopaminergic agonists in Parkinson's disease
    Alonso Canovas, A.
    Luquin Piudo, R.
    Garcia Ruiz-Espiga, P.
    Burguera, J. A.
    Campos Arillo, V.
    Castro, A.
    Linazasoro, G.
    Lopez del Val, J.
    Vela, L.
    Martinez Castrillo, J. C.
    NEUROLOGIA, 2014, 29 (04): : 230 - 241
  • [6] Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson’s disease
    Aditi Verma
    Reddy Peera Kommaddi
    Barathan Gnanabharathi
    Etienne C. Hirsch
    Vijayalakshmi Ravindranath
    Journal of Neural Transmission, 2023, 130 : 495 - 512
  • [7] Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson's disease
    Verma, Aditi
    Kommaddi, Reddy Peera
    Gnanabharathi, Barathan
    Hirsch, Etienne C.
    Ravindranath, Vijayalakshmi
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (04) : 495 - 512
  • [8] Genetic analysis of transcription factors in dopaminergic neuronal development in Parkinson's disease
    Zhao, Yuwen
    Qin, Lixia
    Pan, Hongxu
    Song, Tingwei
    Wang, Yige
    Zhou, Xiaoxia
    Xiang, Yaqin
    Li, Jinchen
    Liu, Zhenhua
    Sun, Qiying
    Guo, Jifeng
    Yan, Xinxiang
    Tang, Beisha
    Xu, Qian
    CHINESE MEDICAL JOURNAL, 2024, 137 (04) : 450 - 456
  • [9] The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease
    Jankovic, J
    Chen, S
    Le, WD
    PROGRESS IN NEUROBIOLOGY, 2005, 77 (1-2) : 128 - 138
  • [10] Genetic analysis of transcription factors in dopaminergic neuronal development in Parkinson’s disease
    Zhao Yuwen
    Qin Lixia
    Pan Hongxu
    Song Tingwei
    Wang Yige
    Zhou Xiaoxia
    Xiang Yaqin
    Li Jinchen
    Liu Zhenhua
    Sun Qiying
    Guo Jifeng
    Yan Xinxiang
    Tang Beisha
    Xu Qian
    中华医学杂志英文版, 2024, 137 (04)